Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Biomolecule-assisted synthesis of Ag/reduced graphene oxide nanocomposite with excellent electrocatalytic and antibacterial performance.

Fathalipour S, Pourbeyram S, Sharafian A, Tanomand A, Azam P.

Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:742-751. doi: 10.1016/j.msec.2017.02.122. Epub 2017 Feb 27.

PMID:
28415524
2.

Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.

Fakhouri F, de Jorge EG, Brune F, Azam P, Cook HT, Pickering MC.

Kidney Int. 2010 Aug;78(3):279-86. doi: 10.1038/ki.2010.132. Epub 2010 May 5.

3.

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.

Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, Fujiwara Y, Mattson DL, Das S, Melvin JE, Pratt PF, Hatoum OA, Gutterman DD, Harder DR, Miura H.

J Clin Invest. 2008 Sep;118(9):3025-37. doi: 10.1172/JCI30836.

4.

Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.

Azam P, Sankaranarayanan A, Homerick D, Griffey S, Wulff H.

J Invest Dermatol. 2007 Jun;127(6):1419-29. Epub 2007 Feb 1.

5.

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.

Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, Wang PH, LeeHealey CJ, S Andrews B, Sankaranarayanan A, Homerick D, Roeck WW, Tehranzadeh J, Stanhope KL, Zimin P, Havel PJ, Griffey S, Knaus HG, Nepom GT, Gutman GA, Calabresi PA, Chandy KG.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17414-9. Epub 2006 Nov 6.

6.

Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.

Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hänsel W, Wulff H.

Mol Pharmacol. 2005 Nov;68(5):1254-70. Epub 2005 Aug 11.

PMID:
16099841
7.

The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers.

Azam P, Peiffer JL, Chamousset D, Tissier MH, Bonnet PA, Vian L, Fabre I, Ourlin JC.

Toxicol Appl Pharmacol. 2006 Apr 1;212(1):14-23. Epub 2005 Jul 21.

PMID:
16039684
8.

Qualitative and quantitative evaluation of a local lymph node assay based on ex vivo interleukin-2 production.

Azam P, Peiffer JL, Ourlin JC, Bonnet PA, Tissier MH, Vian L, Fabre I.

Toxicology. 2005 Jan 15;206(2):285-98.

PMID:
15588920
9.

Replication factor C from the hyperthermophilic archaeon Pyrococcus abyssi does not need ATP hydrolysis for clamp-loading and contains a functionally conserved RFC PCNA-binding domain.

Henneke G, Gueguen Y, Flament D, Azam P, Querellou J, Dietrich J, Hübscher U, Raffin JP.

J Mol Biol. 2002 Nov 8;323(5):795-810.

PMID:
12417194
10.

Characterization of two DNA polymerases from the hyperthermophilic euryarchaeon Pyrococcus abyssi.

Gueguen Y, Rolland JL, Lecompte O, Azam P, Le Romancer G, Flament D, Raffin JP, Dietrich J.

Eur J Biochem. 2001 Nov;268(22):5961-9.

11.

[Retroperitoneal mucinous cystadenoma].

Azam P, Lang H, Lindner V, Roy C, Saussine C, Jacqmin D.

Prog Urol. 1999 Apr;9(2):319-21. French.

PMID:
10370959
12.

[Skin gangrene of the external genitalia. Report of 44 cases].

Brissiaud JC, Azam P, Paret B, Lopy J, Louis C, Collet F.

Chirurgie. 1998 Sep;123(4):387-93. French.

PMID:
9828514

Supplemental Content

Support Center